Citalex 5 mg (Tablet)

Unit Price: ৳ 6.00 (3 x 10: ৳ 180.00)

Strip Price: ৳ 60.00

Medicine Details

Selective serotonin reuptake inhibitor (SSRI)
Pure S-enantiomer of the racemic bicyclic phthalate derivative citalopram
At least 100 fold more potent than the R-enantiomer with respect to inhibition of 5-HT reuptake
No or very low affinity for serotonergic or other receptors including alpha- and beta-adrenergic Dopamine, Histamine, Muscarinic and benzodiazepine receptors

SSRI or related antidepressants should not be started until 2 weeks after stopping an MAOI
An MAOI should not be started until at least a week after an SSRI or related antidepressant has been stopped

Contraindicated in patients with known hypersensitivity to Escitalopram or Citalopram or any of the inactive ingredients of the drug product
Concomitant use of escitalopram in patients taking monoamine oxidase/pimozide is contraindicated

Less sedating and have fewer antimuscarinic and cardiotoxic effects than tricyclic antidepressants
Gastrointestinal effects, anorexia with weight loss or increased appetite and weight gain
Hypersensitivity reactions including rash, urticaria, angioedema, anaphylaxis, arthralgia, myalgia, and photosensitivity
Dry mouth, nervousness, anxiety, headache, insomnia, tremor, dizziness, asthenia, hallucinations, drowsiness, convulsions, galactorrhoea, sexual dysfunction, urinary retention, sweating, hypomania or mania, movement disorders and dyskinesias, visual disturbances

Carefully consider the potential risks and benefits of treatment when treating a pregnant woman during the third trimester
Excreted in human breast milk, decision whether to continue or discontinue nursing or therapy should take into account the risk of exposure for the infant and the benefits of treatment for the mother

Use with caution in patients with epilepsy, cardiac disease, diabetes mellitus, angle-closure glaucoma, hepatic and renal impairment
Discontinue if convulsions develop, prolonged seizures reported with fluoxetine, and history of mania

Elderly patients - Initial dosage is 5 mg once daily
Children and adolescents - Citalex should not be used in the treatment of children and adolescents under the age of 18 years
Dosage adjustment is not necessary in patients with mild or moderate renal impairment
Caution and extra careful dose titration is advised in patients with severely reduced hepatic function
For patients who are known to be poor metabolisers, an initial dose of 5 mg daily during the first two weeks of treatment is recommended

Symptoms range from dizziness, tremor, and agitation to rare cases of serotonin syndrome, convulsion, coma, nausea/vomiting, hypotension, tachycardia, QT interval prolongation, and arrhythmia
No specific antidote, establish and maintain an airway, ensure adequate oxygenation and respiratory function, consider gastric lavage and activated charcoal, monitor cardiac and vital signs, and provide symptomatic supportive measures

Store below 30°C temperature and protect from light & moisture, keep the medicine out of the reach of children